Interestingly, CYP2D6 was identified as a biomarker associated with increased susceptibility to melanoma, which is coded for another enzyme that may play a role in detoxifying potentially carcinogenic compounds (Bose et al., 2018). This evidence concerns the gene CYP2D6 and melanoma.